Literature DB >> 11583735

Specific inhibiting characteristics of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine 'Chuanxiong,' on platelet thrombus formation under high shear rates.

M Li1, S Handa, Y Ikeda, S Goto.   

Abstract

We have investigated the effects of tetramethylpyrazine, one of the active ingredients of the Chinese herbal medicine Chuanxiong, on platelet thrombus formation under flow conditions. We demonstrate herein that tetramethylpyrazine inhibits shear-induced platelet aggregation under relatively high shear rate of 10,800 s(-1) with modest inhibition of those occurring under relatively low shear rate of 1200 s(-1) by using optically modified cone-plate viscometer. We also demonstrate that platelet activation induced by shearing in the absence of exogenous platelet-activating agents such as ADP as evidenced by P-selectin surface expression and microparticle release detected by quantitative flow cytometry was also inhibited by tetramethylpyrazine. Moreover, we also demonstrate platelet thrombus formation on the collagen and von Willebrand factor (vWF) surface at high shear rates without significant influences on those occurring under relatively low shear rates. Because platelet thrombus formation occurring under high shear rates is known to be mediated by the vWF interaction with platelet receptor proteins GP Ibalpha and GP IIb/IIIa, we speculated that tetramethylpyrazine exerts antiplatelet effects by inhibiting the vWF-mediated process of platelet thrombus formation. Our findings, indicating the unique antiplatelet characteristics of tetramethylpyrazine, selectively inhibiting the platelet thrombus formation under high shear rates, provide good reasons for developing chemical analogs having biological functions similar to or more potent than those of tetramethylpyrazine as antiplatelet agents having unique biological functions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11583735     DOI: 10.1016/s0049-3848(01)00343-7

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  14 in total

1.  The prediction of plasma and brain levels of 2,3,5,6-tetramethylpyrazine following transdermal application.

Authors:  Xiaohong Qi; Chrisita Ackermann; Duxin Sun; Rong Liu; Minli Sheng; Huimin Hou
Journal:  AAPS PharmSci       Date:  2002

2.  Effect of tetramethylpyrazine on P-selectin and hepatic/renal ischemia and reperfusion injury in rats.

Authors:  Jin-Lian Chen; Tong Zhou; Wei-Xiong Chen; Jin-Shui Zhu; Ni-Wei Chen; Ming-Jun Zhang; Yun-Lin Wu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 3.  Complications of traditional Chinese/herbal medicines (TCM)--a guide for perplexed oncologists and other cancer caregivers.

Authors:  Joanne Chiu; Thomas Yau; Richard J Epstein
Journal:  Support Care Cancer       Date:  2008-11-14       Impact factor: 3.603

Review 4.  Ligustrazine monomer against cerebral ischemia/reperfusion injury.

Authors:  Hai-Jun Gao; Peng-Fei Liu; Pei-Wen Li; Zhuo-Yan Huang; Feng-Bo Yu; Ting Lei; Yong Chen; Ye Cheng; Qing-Chun Mu; Hai-Yan Huang
Journal:  Neural Regen Res       Date:  2015-05       Impact factor: 5.135

5.  Inhibition of angiogenesis, fibrosis and thrombosis by tetramethylpyrazine: mechanisms contributing to the SDF-1/CXCR4 axis.

Authors:  Xiaoxiao Cai; Zhao Chen; Xueke Pan; Lei Xia; Pei Chen; Ying Yang; Huan Hu; Jing Zhang; Kaijing Li; Jian Ge; Keming Yu; Jing Zhuang
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

6.  Development of Alginate Microspheres Containing Chuanxiong for Oral Administration to Adult Zebrafish.

Authors:  Li-Jen Lin; Chung-Jen Chiang; Yun-Peng Chao; Shulhn-Der Wang; Yu-Ting Chiou; Han-Yu Wang; Shung-Te Kao
Journal:  Biomed Res Int       Date:  2016-06-15       Impact factor: 3.411

Review 7.  Phytochemical and pharmacological review of da chuanxiong formula: a famous herb pair composed of chuanxiong rhizoma and gastrodiae rhizoma for headache.

Authors:  Lu Wang; Jinming Zhang; Yanlong Hong; Yi Feng; Meiwan Chen; Yitao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-27       Impact factor: 2.629

Review 8.  Cardiovascular Actions and Therapeutic Potential of Tetramethylpyrazine (Active Component Isolated from Rhizoma Chuanxiong): Roles and Mechanisms.

Authors:  Ming Guo; Yue Liu; Dazhuo Shi
Journal:  Biomed Res Int       Date:  2016-05-23       Impact factor: 3.411

9.  Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.

Authors:  Jingen Li; Jianqing Ju; Zhuo Chen; Jing Liu; Fang Lu; Rui Gao; Hao Xu
Journal:  Trials       Date:  2018-02-07       Impact factor: 2.279

10.  Natural plant products in treatment of pulmonary arterial hypertension.

Authors:  Lili Xiang; Ying Li; Xu Deng; Djuro Kosanovic; Ralph Theo Schermuly; Xiaohui Li
Journal:  Pulm Circ       Date:  2018-06-05       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.